High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis
Objective To investigate if fibroblast growth factor 18 (FGF18) expression plays an important role in endometrial carcinoma (EC). Methods The clinicopathological associations and prognostic value of FGF18 expression were retrospectively analyzed in 190 patients with EC. FGF18 expression was stably k...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-01-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605241311402 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832587195019427840 |
|---|---|
| author | Zheng-Yao Lei Jian Wu Bao-Hua Zhang Wei Xiang Min Wang Bin-bin Li Ming-Cheng Dai |
| author_facet | Zheng-Yao Lei Jian Wu Bao-Hua Zhang Wei Xiang Min Wang Bin-bin Li Ming-Cheng Dai |
| author_sort | Zheng-Yao Lei |
| collection | DOAJ |
| description | Objective To investigate if fibroblast growth factor 18 (FGF18) expression plays an important role in endometrial carcinoma (EC). Methods The clinicopathological associations and prognostic value of FGF18 expression were retrospectively analyzed in 190 patients with EC. FGF18 expression was stably knocked down in EC cell lines. Changes in cell proliferation, migration, and invasion rates were examined via cell behavior experiments. Tumor growth was investigated using a xenograft mouse model. RNA sequencing (RNA-seq) was performed to identify differentially expressed genes (DEGs) in HEC-1-B cells after FGF18 knockdown, followed by pathway enrichment analysis of the DEGs. Results High FGF18 expression levels were closely correlated with EC clinicopathological features, such as histological subtype, FIGO stage, depth of myometrial invasion, and tumor size. Moreover, EC patients with high FGF18 expression levels had poorer overall survival. FGF18 knockdown in EC cells revealed its role in promoting tumor cell proliferation, migration, and invasion in vitro , as well as tumor growth in vivo . RNA-seq of HEC-1-B cells revealed that the DEGs were enriched in signaling pathways related to cell proliferation and migration. Conclusions Overexpression of FGF18 may serve as a prognostic biomarker for EC patients and is a potential therapeutic target for treating this disease. |
| format | Article |
| id | doaj-art-16c70f861dbb420bbdc1ec1a6eb588a8 |
| institution | Kabale University |
| issn | 1473-2300 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of International Medical Research |
| spelling | doaj-art-16c70f861dbb420bbdc1ec1a6eb588a82025-01-24T15:03:39ZengSAGE PublishingJournal of International Medical Research1473-23002025-01-015310.1177/03000605241311402High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasisZheng-Yao LeiJian WuBao-Hua ZhangWei XiangMin WangBin-bin LiMing-Cheng DaiObjective To investigate if fibroblast growth factor 18 (FGF18) expression plays an important role in endometrial carcinoma (EC). Methods The clinicopathological associations and prognostic value of FGF18 expression were retrospectively analyzed in 190 patients with EC. FGF18 expression was stably knocked down in EC cell lines. Changes in cell proliferation, migration, and invasion rates were examined via cell behavior experiments. Tumor growth was investigated using a xenograft mouse model. RNA sequencing (RNA-seq) was performed to identify differentially expressed genes (DEGs) in HEC-1-B cells after FGF18 knockdown, followed by pathway enrichment analysis of the DEGs. Results High FGF18 expression levels were closely correlated with EC clinicopathological features, such as histological subtype, FIGO stage, depth of myometrial invasion, and tumor size. Moreover, EC patients with high FGF18 expression levels had poorer overall survival. FGF18 knockdown in EC cells revealed its role in promoting tumor cell proliferation, migration, and invasion in vitro , as well as tumor growth in vivo . RNA-seq of HEC-1-B cells revealed that the DEGs were enriched in signaling pathways related to cell proliferation and migration. Conclusions Overexpression of FGF18 may serve as a prognostic biomarker for EC patients and is a potential therapeutic target for treating this disease.https://doi.org/10.1177/03000605241311402 |
| spellingShingle | Zheng-Yao Lei Jian Wu Bao-Hua Zhang Wei Xiang Min Wang Bin-bin Li Ming-Cheng Dai High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis Journal of International Medical Research |
| title | High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis |
| title_full | High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis |
| title_fullStr | High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis |
| title_full_unstemmed | High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis |
| title_short | High FGF18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis |
| title_sort | high fgf18 expression levels predict poor prognosis in endometrial carcinoma patients and promote tumor growth and metastasis |
| url | https://doi.org/10.1177/03000605241311402 |
| work_keys_str_mv | AT zhengyaolei highfgf18expressionlevelspredictpoorprognosisinendometrialcarcinomapatientsandpromotetumorgrowthandmetastasis AT jianwu highfgf18expressionlevelspredictpoorprognosisinendometrialcarcinomapatientsandpromotetumorgrowthandmetastasis AT baohuazhang highfgf18expressionlevelspredictpoorprognosisinendometrialcarcinomapatientsandpromotetumorgrowthandmetastasis AT weixiang highfgf18expressionlevelspredictpoorprognosisinendometrialcarcinomapatientsandpromotetumorgrowthandmetastasis AT minwang highfgf18expressionlevelspredictpoorprognosisinendometrialcarcinomapatientsandpromotetumorgrowthandmetastasis AT binbinli highfgf18expressionlevelspredictpoorprognosisinendometrialcarcinomapatientsandpromotetumorgrowthandmetastasis AT mingchengdai highfgf18expressionlevelspredictpoorprognosisinendometrialcarcinomapatientsandpromotetumorgrowthandmetastasis |